I suppose that the future will be clearer after the teva November meeting as well, though, if the teva website is any guide, msb won't rate a mention. I find it strange that given the teva uncertainty has been around since June, that teva itself hasn't clarified its position. We've heard the msb version, the life scientist version, many analyst versions, but curiously not a sound from teva.
though science is their profession and not investor relations.
punched below 200 day ma - i'm out!, page-8
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.070(6.57%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | 99.5¢ | $3.980M | 3.944M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 56239 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 103125 | 2 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |